Intersect ENT Owners | StatInvestor

Health Care & Life Sciences » Medical Equipment & Supplies | Intersect ENT Inc.

Intersect ENT Inc. | Ownership

Companies that own Intersect ENT Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Wellington Management Co. LLP

2,966,913

9.74%

-148,467

0.02%

06/30/2018

Deerfield Management Company LP

2,093,000

6.87%

1,073,000

1.75%

08/01/2018

BlackRock Fund Advisors

1,997,121

6.56%

235,835

06/30/2018

HealthCor Management LP

1,950,000

6.4%

681,150

1.65%

08/01/2018

Invesco Advisers, Inc.

1,597,837

5.25%

146,365

0.03%

06/30/2018

AllianceBernstein LP

1,449,121

4.76%

-45,202

0.02%

06/30/2018

Jennison Associates LLC

1,312,420

4.3%

-362,332

0.03%

06/30/2018

The Vanguard Group, Inc.

1,267,205

4.16%

15,677

06/30/2018

FIAM LLC

917,784

3.01%

272,880

0.05%

06/30/2018

Federated Global Investment Management Corp.

884,200

2.9%

600

0.19%

06/30/2018

About Intersect ENT

View Profile

Address	1555 Adams Drive Menlo Park California 94025 United States
Employees	-
Website	http://www.intersectent.com
Updated	07/08/2019
Intersect ENT, Inc. is acommercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.